Answers are grounded in this paper and cite their sources.
Uniform flow cytometry data analysis substantially reduced inter-laboratory variation in reporting multiple components of the MM MRD assay. Adoption of a harmonized approach would meet an important need for conformity in reporting MM MRD for clinical trials, and wider acceptance of MM MRD as a surrogate clinical endpoint.
No takes yet. Share an insight, caveat, or question.
Soh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: